197 related articles for article (PubMed ID: 29785118)
1. Traditional Chinese medicine
Wu J; Wang J; Su Q; Ding W; Li T; Yu J; Cao B
Onco Targets Ther; 2018; 11():2685-2698. PubMed ID: 29785118
[TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.
Wu J; Yu J; Wang J; Zhang C; Shang K; Yao X; Cao B
Biomed Pharmacother; 2018 Apr; 100():176-183. PubMed ID: 29428665
[TBL] [Abstract][Full Text] [Related]
3. The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells.
Li H; Fan Y; Yang F; Zhao L; Cao B
Oncol Lett; 2018 Jul; 16(1):353-361. PubMed ID: 29928421
[TBL] [Abstract][Full Text] [Related]
4. Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.
Zhen H; Li G; Zhao P; Zhang Y; Wang J; Yu J; Cao B
Onco Targets Ther; 2020; 13():12325-12339. PubMed ID: 33293826
[TBL] [Abstract][Full Text] [Related]
5. Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways.
Hu Y; Jing J; Shi Y; Zhang P; Dong D; Wu Y; Dong X; Li E; Fan Y
Transl Cancer Res; 2021 Jul; 10(7):3306-3316. PubMed ID: 35116637
[TBL] [Abstract][Full Text] [Related]
6. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.
Chen S; Yao L
Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839
[TBL] [Abstract][Full Text] [Related]
7. Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
Zhen H; Tian J; Li G; Zhao P; Zhang Y; Che J; Cao B
BMC Cancer; 2023 Mar; 23(1):207. PubMed ID: 36870981
[TBL] [Abstract][Full Text] [Related]
8. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
Yu X; Fan H; Jiang X; Zheng W; Yang Y; Jin M; Ma X; Jiang W
Oncol Lett; 2020 Oct; 20(4):52. PubMed ID: 32788939
[TBL] [Abstract][Full Text] [Related]
9. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
11. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
12. Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.
Ma Y; Yu J; Li Q; Su Q; Cao B
Biosci Biotechnol Biochem; 2020 Apr; 84(4):743-756. PubMed ID: 31889475
[TBL] [Abstract][Full Text] [Related]
13. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
14. The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo.
Liu M; Wang X; Li H; Xu L; Jing L; Jiang P; Liu B; Li Y
Thorac Cancer; 2019 Oct; 10(10):1868-1878. PubMed ID: 31486270
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effect of Astragalus Polysaccharide Combined with Cisplatin on Cell Cycle and Migration of Nasopharyngeal Carcinoma Cell Lines.
Yang YL; Lin ZW; He PT; Nie H; Yao QY; Zhang SY
Biol Pharm Bull; 2021 Jul; 44(7):926-931. PubMed ID: 33952795
[TBL] [Abstract][Full Text] [Related]
16. Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma.
Wang YM; Xu X; Tang J; Sun ZY; Fu YJ; Zhao XJ; Ma XM; Ye Q
Cell Biosci; 2021 Jul; 11(1):124. PubMed ID: 34229754
[TBL] [Abstract][Full Text] [Related]
17. Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy.
Liu X; Zheng Q; Yu Q; Hu Y; Cheng Y; Shao Z; Chen L; Ding W; Gao D
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):1009-1018. PubMed ID: 33205247
[TBL] [Abstract][Full Text] [Related]
18. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
19. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
20. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]